Ardelyx | ARDX - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Amgen USD 1.58B 354M 2026-03
Ardelyx USD 75.92M 7.69M 2025-12
aTyr Pharma USD 82.26M 77.46M 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Curis USD 1.34M 3.45M 2025-12
Sanofi EUR 2.75B 455M 2025-12
TG Therapeutics USD 73.14M 22.42M 2026-03
United Therapeutics USD 156.6M 34M 2026-03
Xoma USD 11M 2.54M 2024-06